Results 231 to 240 of about 411,260 (349)

Enhanced response inhibition in patients with drug-resistant juvenile myoclonic epilepsy: Event-related potentials evidence of excitatory-inhibitory imbalance. [PDF]

Epilepsia Open
Sarah L, Yam M, Goldstein L, Fahoum F, Noam BE, Maidan I.   +5 more
europepmc   +1 more source

Performance monitoring is altered in adult ADHD: A familial event-related potential investigation

, 2009
Gráinne McLoughlin, Bjoern Albrecht, Tobias Banaschewski, Aribert Rothenberger, Daniel Brandeis, Philip Asherson, Jonna Kuntsi   +6 more
openalex   +1 more source

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

Molecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti, Giovanni Germano, Pietro Paolo Vitiello, Alberto Bardelli   +3 more
wiley   +1 more source

Differences in event-related potentials between unipolar depression and bipolar II disorder during depressive episodes: a retrospective case-control study. [PDF]

BMC Psychiatry
Zhou X, Liu J, Lin Z, Xiang M, Deng X, Zou Z.   +5 more
europepmc   +1 more source

Test-retest reliability of infant event related potentials evoked by faces

, 2017
Nicolette M. Munsters, Heleen van Ravenswaaij, Carlijn van den Boomen, Chantal Kemner   +3 more
openalex   +1 more source

Temporal features of individual and collective self-referential processing: an event-related potential study

, 2020
Cuihong Liu, Wenjie Li, Rong Wang, Yaohan Cai, Jie Chen   +4 more
openalex   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

EEG Baseline Analysis for Effective Extraction of P300 Event-Related Potentials for Welfare Interfaces. [PDF]

Sensors (Basel)
Sasatake Y, Matsushita K.
europepmc   +1 more source

Event-related potential studies of prefrontal cortex contributions to episodic retrieval [PDF]

, 2010
Damian Cruse
openalex  

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

Molecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken, Andrea Abel Gutierrez, Imke van Rossum, Cornelia G. Spruijt, Michiel Vermeulen, Guido van Mierlo, Blanca Scheijen, Annemiek B. van Spriel   +7 more
wiley   +1 more source